资讯

Eli Lilly: Positioned For Robust Q1 As Orforglipron Enhances Long-Term Outlook
Eli Lilly's Orforglipron shines in Phase III trials, potentially leading diabetes and obesity treatment by 2026. See what to ...
BizWest10 小时
For bioscientists facing funding cuts, tariffs: ‘It’s grim out there’
Perhaps no industry is as reliant on grant-funded university research as is bioscience, the companies that develop ...
Raman Spectroscopy Market Size to Hit USD 2.00 Billion by 2032, at a CAGR of 7.51% ...
Raman Spectroscopy Market Size & Growth Insights: According to the SNS Insider Report, “The Raman Spectroscopy Market was valued at USD 1.04 billion in 2023 and is projected to reach USD 2.00 billion ...
The Harvard Crimson20 小时
Harvard Built the Biotech Industry in Cambridge, Then Let It Go. Now It Wants Back In.
Kendall Square has become a hub of biotech innovation and a popular location for up and coming life sciences firms. Now, a ...
Indiatimes7 小时
Glenmark Life Share Price Returns
Alivus Life Sciences Ltd., incorporated in the year 2011, is a Small Cap company (having a market cap of Rs 12,698.51 Crore) operating in Pharmaceuticals sector. Alivus Life Sciences Ltd. key Products ...